Immuneering Corporation (IMRX)
NASDAQ: IMRX · Real-Time Price · USD
1.925
+0.065 (3.49%)
Nov 5, 2024, 1:14 PM EST - Market open
Immuneering Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Nov '24 Nov 5, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Market Capitalization | 55 | 215 | 128 | 426 | - | - |
Market Cap Growth | -87.20% | 67.99% | -69.91% | - | - | - |
Enterprise Value | -0 | 122 | 16 | 267 | - | - |
Last Close Price | 1.86 | 7.35 | 4.85 | 16.17 | - | - |
PE Ratio | - | -3.91 | -2.53 | -6.56 | - | - |
PS Ratio | - | - | 404.05 | 204.62 | - | - |
PB Ratio | 0.83 | 2.38 | 1.17 | 2.73 | - | - |
P/FCF Ratio | -0.74 | -4.36 | -2.86 | -13.77 | - | - |
P/OCF Ratio | -0.75 | -4.39 | -2.90 | -13.80 | - | - |
EV/Sales Ratio | - | - | 49.59 | 128.17 | - | - |
EV/EBITDA Ratio | 0.48 | -2.11 | -0.31 | -7.88 | - | - |
EV/EBIT Ratio | 0.48 | -2.10 | -0.30 | -7.87 | - | - |
EV/FCF Ratio | 0.57 | -2.48 | -0.35 | -8.62 | - | - |
Debt / Equity Ratio | 0.07 | 0.05 | 0.04 | 0.03 | 0.02 | 0.35 |
Debt / FCF Ratio | -0.08 | -0.09 | -0.11 | -0.17 | -0.04 | -0.79 |
Asset Turnover | - | - | 0.00 | 0.02 | 0.09 | - |
Quick Ratio | 8.81 | 10.92 | 13.10 | 26.53 | 16.66 | 27.69 |
Current Ratio | 9.39 | 11.35 | 13.50 | 27.04 | 16.73 | 27.83 |
Return on Equity (ROE) | -61.81% | -53.36% | -38.00% | -35.01% | -74.56% | - |
Return on Assets (ROA) | -37.42% | -32.46% | -22.38% | -20.65% | -40.66% | - |
Return on Capital (ROIC) | -39.70% | -34.81% | -23.43% | -21.44% | -42.85% | - |
Earnings Yield | -101.65% | -24.86% | -39.44% | -7.88% | - | - |
FCF Yield | -92.68% | -22.92% | -35.02% | -7.26% | - | - |
Buyback Yield / Dilution | -8.98% | -7.69% | -93.84% | -175.00% | 0.00% | - |
Total Shareholder Return | -8.98% | -7.69% | -93.84% | -175.00% | 0.00% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.